Manager × security

Venrock Adviser, LLC ORIC holdings history

Who else holds this security? →

ORIC PHARMACEUTICALS INC · CUSIP 68622P109 · CIK 1615982

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, Venrock Adviser, LLC reported 2.94M ORIC (shares), valued at $39.66M, or 1.93% of its reported non-derivative portfolio. Filed Nov 16, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.93%
Shares
2.94M
2,944,056
Reported value
$39.66M
USD

Shares decreased 31.85%; reported value decreased 15.23%, and weight changed +0.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20261.93%2,944,056SEC filing ↗Filed Nov 16, 2026
Q2 20261.42%4,319,765SEC filing ↗Filed Aug 14, 2026
Q1 20262.04%4,319,765SEC filing ↗Filed May 15, 2026
Q4 20252.29%5,676,230SEC filing ↗Filed Feb 17, 2026
Q3 20254.46%6,596,885SEC filing ↗Filed Nov 14, 2025
Q2 20255.02%6,596,885SEC filing ↗Filed Aug 14, 2025
Q1 20251.51%3,182,527SEC filing ↗Filed May 15, 2025
Q4 20242.43%4,394,527SEC filing ↗Filed Feb 14, 2025
Q3 20242.36%4,394,527SEC filing ↗Filed Nov 14, 2024
Q2 20241.98%4,394,527SEC filing ↗Filed Aug 14, 2024
Q1 20242.87%4,394,527SEC filing ↗Filed May 15, 2024
Q4 20231.53%2,428,385SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.53%2,428,385$22.34MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20242.87%4,394,527$60.42MShares increased 80.97%; reported value increased 170.46%, and weight changed +1.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20241.98%4,394,527$31.07MShares unchanged; reported value decreased 48.58%, and weight changed -0.89 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20242.36%4,394,527$45.04MShares unchanged; reported value increased 44.98%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20242.43%4,394,527$35.46MShares unchanged; reported value decreased 21.27%, and weight changed +0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.51%3,182,527$17.76MShares decreased 27.58%; reported value decreased 49.93%, and weight changed -0.92 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20255.02%6,596,885$66.96MShares increased 107.28%; reported value increased 277.05%, and weight changed +3.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20254.46%6,596,885$79.16MShares unchanged; reported value increased 18.23%, and weight changed -0.56 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20252.29%5,676,230$46.43MShares decreased 13.96%; reported value decreased 41.35%, and weight changed -2.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20262.04%4,319,765$54.73MShares decreased 23.90%; reported value increased 17.88%, and weight changed -0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20261.42%4,319,765$46.78MShares unchanged; reported value decreased 14.52%, and weight changed -0.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 20261.93%2,944,056$39.66MShares decreased 31.85%; reported value decreased 15.23%, and weight changed +0.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 16, 2026
Venrock Adviser, LLC · ORIC PHARMACEUTICALS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1615982","quarter":"2026Q3","cusip":"68622P109"}

akkru_institutional_holdings
{"action":"history","cik":"1615982","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.